As observed in breast cancer cells, silibinin, rottlerin, salinomycin and niclosamide were demonstrated to inhibit WNT/β-catenin activity and pancreatic cancer cell growth by suppressing LRP6 expression or phosphorylation (Table 2) [95,96,97,100]. The gene discussed is LRP6; the disease is breast carcinoma.